Skip to main content
$0.12 -0.02 (-12.78%) At close · Jul 24
Market Cap
$1.09M
Shares
9.02M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.13 Open$0.14 Day$0.13–0.14 52W$0.12–3.21 Avg vol 30d7.8M Short int214K · 2.4% float · 1.0d Short vol34% DataMay 2020–Jul 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.6 · elevated Equity put/call 0.61
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −85%
below
Price vs 50-day avg −36%
below
RSI (14) 34
neutral
MACD trend Positive
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return −17%
trailing
6-month return −90%
trailing
YTD return −90%
this year
Relative strength −97%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
1 of 10 funds reported for Jun 30 · net 0 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.37% of float · ▼ -42.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
10 holders — near 1-yr low, contrarian setup
Squeeze score 34
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 107%
annualized · 1-yr
Max drawdown −96%
past year
ATR 14.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−85% Bearish
Price vs 50-day avg
−36% Bearish
RSI (14)
34 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
1 of 10 funds reported for Jun 30 · net 0 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.37% of float · ▼ -42.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
10 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0 Now $0 · 0% 52-wk high $3
vs 200-day avg -85% vs 50-day avg -36%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IMCC
IM Cannabis Corp.
this stock
$1.09M -90.4% 2.4%
TAK
Takeda Pharmaceutical Co Ltd
$55.06B +10.6% 0.1%
GALDY
Galderma Group AG/ADR
$49.54B +2.5% 0.0%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
$45.13B 0.0%
HLN
Haleon plc
$43.07B -4.0% 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
10
% held
0.3%
Reported
1 of 10
Top holder
Hidden Cove Wealth Manage…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
214.0K
Days to cover
1.0d
Change
-159.5K sh
View
Short Volume
Short vol %
34%
As of
Jul 24, 2026
Short Total
View
Fails to Deliver
FTD shares
379
Value
$61
As of
Jun 24, 2026
View
Off-Exchange
Off-exchange %
66.0%
Week of
May 4, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 1, 2026
This year
13
View
Exempt Offerings
Offering
$67.2K
Filed
Nov 20, 2024
View

Performance

5D 20D 120D MTD YTD
IMCC -6.3% -16.9% -90.2% -20.8% -90.4%
SPY -1.7% +0.7% +6.4% -1.2% +8.3%
vs SPY -4.7% -17.6% -96.5% -19.7% -98.7%
Key facts CIK 1792030 CUSIP 44969Q406 13F (30d) 1 filings 1 filers Visit website Investor relations